N,N-Diethyl-4-(4-((3-(piperidin-1-yl)propyl)amino)quinolin-2-yl)benzamide hydrochloride

Catalog No. :
ACPUOA753
CAS No. :
2310135-38-5
Molecular Formula :
C28H37ClN4O
Molecular Weight :
481.08

IUPAC Name:N,N-diethyl-4-(4-((3-(piperidin-1-yl)propyl)amino)quinolin-2-yl)benzamide hydrochloride

N,N-Diethyl-4-(4-((3-(piperidin-1-yl)propyl)amino)quinolin-2-yl)benzamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$255.00Login to see priceInquiryInquiry
5mg98%$641.00Login to see priceInquiryInquiry
10mg98%$912.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,N-Diethyl-4-(4-((3-(piperidin-1-yl)propyl)amino)quinolin-2-yl)benzamide hydrochloride
IUPAC NameN,N-diethyl-4-(4-((3-(piperidin-1-yl)propyl)amino)quinolin-2-yl)benzamide hydrochloride
Molecular FormulaC28H37ClN4O
Molecular Weight481.08
SMILESO=C(N(CC)CC)C1=CC=C(C2=NC3=CC=CC=C3C(NCCCN4CCCCC4)=C2)C=C1.[H]Cl
InChI KeyWYRLEOWACOXSQP-UHFFFAOYSA-N
SynonymLMPTP Inhibitor 1 HCl;LMPTP INHIBITOR 1 hydrochloride, 10 mM in DMSO
CAS No.2310135-38-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPUOA753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPUOA753 route product structure diagram
    ACPUOA7532310135-38-5
Inquiry

2. ACPUOA753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOEJR193 route compound structure diagram
    ACOEJR193325142-99-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPUOA753 route product structure diagram
    ACPUOA7532310135-38-5
Inquiry

Comments (0)